All In Biotech

Free tool

FAERS Monitor: Vancocin Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050606 or its brand name (Vancocin Hydrochloride, Vancomycin Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

8,212

Serious

7,409

90% of reports

Hospitalization

3,669

Death reported

1,633

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective874
  • acute kidney injury582
  • off label use519
  • pyrexia482
  • rash345
  • drug reaction with eosinophilia and systemic symptoms317
  • pneumonia310
  • sepsis310
  • drug hypersensitivity305
  • diarrhoea296
  • condition aggravated283
  • hypotension258
  • renal failure254
  • dyspnoea240
  • pruritus226

Reports by year received

View as table
YearReports
200461
200551
200692
2007150
2008271
2009101
201092
2011108
2012167
2013236
2014217
2015320
2016230
2017244
2018361
2019468
2020524
2021682
2022964
2023959
2024818
2025699
2026396

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,947 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug reaction with eosinophilia and systemic symptomsSignal31731.928.69,363
acute kidney injurySignal5829.89.04,591
sepsisSignal3107.16.41,633
renal failureSignal2544.94.3790
drug hypersensitivitySignal3054.03.6700
pyrexiaSignal4823.63.3903
hypotensionSignal2583.32.9414
pneumoniaSignal3102.52.2269
condition aggravatedSignal2832.42.1229
rashSignal3452.01.8182
drug ineffective8741.71.6267
off label use5191.51.495
pruritus2261.51.339
diarrhoea2961.21.18
dyspnoea2401.11.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.